Status:
UNKNOWN
Higher Versus Standard Dose of Amoxicillin-clavulanate in Pediatric PBB
Lead Sponsor:
Second Affiliated Hospital of Wenzhou Medical University
Conditions:
Protracted Bacterial Bronchitis
Eligibility:
All Genders
2-6 years
Phase:
NA
Brief Summary
Chronic wet cough is one of the most common symptoms of respiratory diseases in children. Protracted bacterial bronchitis (protracted bacterial bronchitis, PBB) is the most common cause of chronic wet...
Detailed Description
Chronic cough is one of the common reasons for children seeking medical treatment. In children, chronic cough is associated with impaired quality of life, multiple doctor visits, and adverse effects f...
Eligibility Criteria
Inclusion
- Children diagnosed with first-onset PBB
- Subjects and their guardians agree to participate in the study and sign an informed consent
Exclusion
- Seriously delayed development of the nervous system;
- With severe underlying diseases: such as severe neuromuscular diseases, immunodeficiency, malnutrition, heart diseases, congenital respiratory system malformation, and other diseases of the heart, brain, liver, kidney and blood system;
- Other diseases that can cause chronic wet cough, including chronic rhinitis, sinusitis, interstitial lung disease, and clinical suspicion of bronchiectasis;
- With poor compliance and expected difficulty in completing the study;
- Other conditions considered inappropriate by the researcher.
Key Trial Info
Start Date :
May 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04378231
Start Date
May 1 2020
End Date
July 1 2022
Last Update
May 7 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.